Natural retinoids inhibit proliferation and induce apoptosis in pancreatic cancer cells previously reported to be retinoid resistant

Cancer Biology and Therapy

Volumn 4, Issue 4, 2005, Pages 480-489

  El Metwally, Tarek H ^a,b,f   Hussein, Mahmoud R ^c   Pour, Parviz M ^d,e   Kuszynski, Charles A ^d,e   Adrian, Thomas E ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ASSIUT UNIVERSITY   (Egypt)

^c Assiut University   (Egypt)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f Assiut University Faculty of Medicine   (Egypt)

Author keywords

Apoptosis; Cancer cell proliferation; Differentiation; Pancreatic cancer; Retinoic acid

Indexed keywords

RETINOIC ACID; RETINOID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL COUNT; CELL CYCLE; CELL PROLIFERATION; DRUG EFFECT; ELECTRON MICROSCOPY; ELECTROPHORESIS; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NICK END LABELING; PANCREAS ADENOCARCINOMA; PANCREAS CANCER;

EID: 25144449101     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.4.4.1701     Document Type: Article

References (53)

1. Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H. Molecular pathology of primary and metastatic ductal pancreatic lesions: Analysis of mutations and expression of the p53, mdm2, p21/waf-1 genes in sporadic and familial lesions. Cancer 1997; 79:700-16.
2. McCormick FC, Lemoine NR. Molecular basis of pancreatic cancer: Strategies for genetic diagnosis and therapy. In: Johnson CD, Imrie CW, eds. Pancreatic disease towards the year 2000. London: Springer-Verlag, 1999:267-80.
3. Rosenberg L. Pancreatic cancer: A review of emerging therapies. Drugs 2000; 59:1071-89.
4. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997; 278:1073-7.
5. Miller WH. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer 1998; 83:1471-82.
6. Egawa N, Maillet B, VanDamme B, De Greve J, Kloppel G. Differentiation of pancreatic carcinoma induced by retinoic acid or sodium butyrate: A morphological and molecular analysis of four cell lines. Verchows Arch 1996; 429:59-68.
7. Rosewicz S, Stier U, Brembeck F, Kaiser A, Papadimitriou CA, Berdel WE, Wiedenmann B, Riechen EO. Retinoids: Effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology 1995; 109:1646-60.
8. Rosewicz S, Brembeck F, Kaiser A, Marschall ZV, Riecken EO. Differential growth regulation by all-trans retinoic acid is determined by protein kinase Cα in human pancreatic carcinoma cells. Endocrinology 1996; 137:3340-7.
9. 1-integrin receptors. Gastroenterology 1997; 112:532-42.
10. Bold RJ, Ishizuka J, Townsend CM, Thompson JC. All-trans retinoic acid inhibits growth of human pancreatic cancer cell lines. Pancreas 1996; 12:189-95.
11. Zugmaier G, Jager R, Grage B, Gottardis MM, Havemann K, Knabbe C. Growth -inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells. Br J Cancer 1996; 73:1341-6.
12. Vickers SM, Sampson LK, Ying W, Phillips JO. Receptor dependent growth inhibition of human pancreatic cancer by 9-cis retinoic acid. J Gastrointest Surg 1997; 1:174-81.
13. Frazier ML, Lilly BJ, Wu EF, Ota T, Hewett-Emmett D. Carbonic anhydrase gene expression in cell lines from human pancreatic adenocarcinoma. Pancreas 1990; 5:507-14.
14. Lu X-P, Fanjul A, Picard N, Pfahl M, Rungta D, Nared-Hood K, Carter B, Piedrafita J, Tang S, Fabbrizio E, Pfahl M. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nature Med 1997; 3:686-90.
15. Kaiser A, Herbst H, Fisher G, Koenigsmann M, Berdel WE, Riechen EO, Rosewicz S. Retinoic acid receptor β regulates growth and differentiation in human pancreatic carcinoma cells. Gastroenterology 1997; 133:920-9.
16. Kaiser A, Wolf-Breitinger M, Albers A, Dorbic T, Witting B, Riecken EO, Rosewicz S. Retinoic acid receptor γ1 expression determines retinoid sensitivity in pancreatic carcinoma cells. Gastroenterology 1998; 115:967-77.
17. Kawa S, Nikaido T, Aoki Y, Zhai Y, Kumagaya T, Furihata S, Fujii S, Kiyosawa K. Arotinoid mofarotene (Ro 40-8757) upregulates p21 and p27 during growth inhibition of pancreatic cancer cell lines. Int J Cancer 1997; 72:906-11.
18. Jimi S, Shono T, Tanaka M, Tanaka M, Kono A, Yamada Y, Shudo K, Kuwano M. Effect of retinoic acid on morphological changes of human pancreatic cancer cells on collagen gels. A possible association with the metastatic potentials. Oncol Res 1998; 10:7-14.
19. El-Metwally TH, Adrian TE. Optimization of treatment conditions for studying the anticancer effects of retinoids using pancreatic adenocarcinoma as a model. Biochem Biophys Res Comm 1999; 257:596-603.
20. Que F, Gores GJ. Apoptosis and the gastrointestinal system. Adv Pharmacology 1997; 41:409-28.
21. Perugini RA, McDade TP, Vittimberga FJ, Callery MP. The molecular and cellular biology of pancreatic cancer. Crit Rev Eukaryot Gene Expr 1998; 8:377-93.
22. Kerr JF, Winterford CM, Harmon BV. Apoptosis, its significance in cancer and cancer therapy. Cancer 1994; 73:2013-26.
23. DiPaola RS, Aisner J. Overcoming Bcl-2- and p53-mediated resistance in prostate cancer. Semin Oncolg 1999; 26:112-6.
24. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-myc is inhibited by Bcl-2. Nature (Lond.) 1992; 359:552-4.
25. Ioannou YA, Chen FW. Quantitation of DNA fragmentation in apoptosis. Nucleic acid Res 1996; 245:992-3.
26. Mesner Jr PW, Kaufmann SH. Methods utilized in the studying of apoptosis. Advances Pharamacol 1997; 41:57-87.
27. Choudhury A, Singh RK, Moniaux N, El-Metwally TH, Aubert JP, Batra SK. Retinoic Acid-dependent transforming growth factor-β2-mediated induction of MUC4 mucin expression in human pancreatic tumor cells follows retinoic acid receptor-α signaling pathway. J Biol Chem 2000; 275:33929-36.
28. Grandis JR, Zeng Q, Tweardy DJ. Retinoic acid normalized the increased gene transcription rate of TGFα and EGFR in head and neck cancer cell lines. Nature Med 1996; 2:237-40.
29. Falk L, De Benedetti F, Lohrey N, Brichenall-Roberts MC, Ellingsworth LW, Faltynek CR, Ruscetti FW. Induction of TGFβ1 receptor expression and TGFβ1 protein production in retinoic acid-treated HL-60 cells: Possible TGFβ-mediated autocrine inhibition. Blood 1991; 77:1248-55.
30. El-Metwally TH, Pour PM, Kuszynski CA, Adrian TE. Differentiation is a prerequisite for apoptosis in pancreatic cancer cells treated, with retinoids. Pancreas 1998; 17:432.
31. El-Deriny SE, O'Brien MJ, Christensen TG, Kupchik HZ. Ultrastructural differentiation and CEA expression of butyrate-treated human pancreatic carcinoma cells. Pancreas 1987; 2:25-33.
32. Chen CS, Mrksich M, Huang S, Whitesides GM, Ingber DE. Geometric control of cell life and death. Science 1997; 276:1425-8.
33. Harmon BV, Allan DJ. Apoptosis. Adv Genetics 1997; 35:35-56.
34. Staunton MJ, Gaffney EF. Apoptosis, basic concepts and potential significance in human cancer. Arch Pathol Lab Med 1998; 122:310-9.
35. Bouvet M, Bold RJ, Evans DB, Lee J, Evans DB, Abbruzzese JL, Chiao PJ, McConkey DJ, Candra J, Chada S, Fang B, Roth JA. Adenovirus-mediated wild type p53 tumor suppressor gene therapy induced apoptosis and suppresses growth of human pancreatic cancer. Ann Surg Oncol 1998; 5:681-8.
36. waf1 expression and growth inhibition by transforming factor β involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer Res 1997; 57:3929-34.
37. Lang D, Miknyoczki SJ, Huang L, Ruggeri BA. Stable reintroduction of wild type p53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells. Oncogene 1998; 16:1593-602.
38. Petit PX, Susin S-A, Zamzami N, Mignotte B, Kroemer G. Mitochondria and programmed cell death: Back to the future. FEBS Lett 1996; 396:7-13.
39. Aoshiba K, Rennard S, Spurzem J. Cell-matrix and cell-cell interactions modulate apoptosis of bronchial epithelial cells. Am J physiol 1997; 72:L28-37, (Lung Cell Mol Physiol).
40. King KL, Cidlowski JA. Cell cycle regulation and apoptosis. Annu Rev Physiol 1998; 60:601-17.
41. Muschel RJ, Mckenna WG, Bernhard EJ. Cell cycle checkpoints and apoptosis: Potential for improving radiation therapy. Vitamins and hormones 1997; 53:1-25.
42. Toma S, Isnardi L, Raffo P, Dastoli G, De-Francisci E, Riccardi L, Palumbo R, Bollag W. Effects of all-trans retinoic acid and 13-cis retinoic acid on breast cancer cell lines: Growth inhibition and apoptosis induction. Int J Cancer 1997; 70:619-27.
43. Mogaki M, Hirota M, Chaney WG, Pour PM. Comparison of p53 protein expression and cellular localization in human and hamster pancreatic cancer cell lines. Carcinogenesis 1993; 14:2587-94.
44. Heerdt BG, Houston MA, Anthony GM, Augenlicht LH. Mitochondrial membrane potential in the coordination of p53-independent proliferation and apoptosis pathways in human colonic carcinoma cells. Cancer Res 1998; 58:2869-75.
45. Dang CV, Semenza GL. Oncogenic alteration of metabolism. TIBS 1999:68-72.
46. Piacentini M. Tissue transglutaminase; A candidate effector element of physiological cell death. Curr Top Microbiol Immunol 1995; 200:163-75.
47. Yan ZH, Noonan S, Nagy L, Davies PJ, Stein JP. Retinoic acid induction of tissue transglutaminase promoter is mediated by a novel response element. Mol Cell Endocrinol 1996; 120:203-12.
48. Zhang L-X, Mills KJ, Dawson MI, Collins SJ, Jetten AM. Evidence for the involvement of retinoic acid receptor RARα-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids. J Biol Chem 1995; 270:6022-9.
49. Katoh S, Nakagawa N, Yano Y, Satoh K, Kohno H, Ohkubo Y. Transglutaminase induced by epidermal growth factor negatively regulates the growth signal in primary cultured hepatocyte. Biochem J 1996; 313:305-9.
50. Kojima S, Nara K, Rifkin D. Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Biol 1993; 121:439-48.
51. Kosa K, Meyers K, Luca LM. Transformation of NIH cells with ras oncogenes abrogates the retinoic acid induction of tissue transglutaminase. Biochem Biophys Res Comm 1993; 196:1025-33.
52. Rubin AL, Rice RH. 2,3,7,8-tetrachlorodibenzo-p-dioxin and polycyclic aromatic hydrocarbons suppress retinoid-induced tissue transglutaminase in SCC-4 cultured human squamous carcinoma cells. Carcinogenesis 1988; 9:1067-70.
53. Piao YF, Shi Y, et al. Inhibitory effect of all-trans retinoic acid on human hepatocellular carcinoma cell proliferation. World J Gastroenterol 2003; 9:2117-20.